Are Benzodiazepines the New Opioids?
Yale addiction specialists believe the primary care system can play a key role in preventing another medication epidemic. David A. Fiellin, MD, worries that otherwise, the trajectory of benzodiazepine prescriptions might lead to a situation that resembles the opioid crisis.
Yale Sleep Researchers Awarded $4.6M To Study Sleep Deficiency / Opioid Use Disorder
Henry Klar Yaggi, MD, MPH, associate professor of medicine; vice chief of Research at Yale’s Section of Pulmonary, Critical Care & Sleep Medicine, director of the Yale Centers for Sleep Medicine, and an investigator at the VA CT Clinical Epidemiology Research Center (CERC) was recently awarded a grant through The Helping to End Addiction Long-term, or the NIH HEAL Initiative.
Yale Investigators Receive NIH HEAL Grants to Study Solutions to the Opioid Crisis
Yale researchers representing a range of disciplines have been awarded grants through the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative (HEAL). This national effort provides $945 million in total funding to support a variety of research projects that tackle the opioid addiction and overdose crisis.
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Suicide is Preventable. So, How Can We Help Our Teens?
Suicide is preventable, but rates of suicide are increasing worldwide, and it is now the second leading cause of death in adolescents and young adults (unintentional motor vehicle accidents are first). Going to the emergency room may be the smartest thing these teenagers can do.
More Vaping-Related Dangers?
According to a recent Yale study, inhaling vapor from flavored e-cigarette liquid exposes users to previously undetected chemical byproducts called acetals. As a result of the study, the authors hope the FDA will begin to study the short- and long-term effects of inhaled acetals.
Stephanie O’Malley appointed the Mears/Jameson Professor of Psychiatry
Stephanie Samples O’Malley, recently named as the Elizabeth Mears and House Jameson Professor of Psychiatry, focuses her research on the development of more effective treatments for substance use disorders, primarily the abuse of alcohol and tobacco, and research supporting effective policies to regulate tobacco.
Yale Launches New Policy Lab to Elevate Mental Health and Disrupt Poverty
Elevate is a new policy laboratory stemming from the successful work of the Mental health Outreach for MotherS (MOMS) Partnership and joining forces with Women’s Health Research at Yale (WHRY) to apply science to the creation and spread of evidence-based interventions for socially and economically disadvantaged families in partnership with government agencies.